Browse result page of CancerPDF Database
Please click on CancerPDF_ID for detailed information about peptide.
| CancerPDF_ID | Peptide seq | Protein Name | Fluid | Mass/Z | Profiling Technique | Cancer Type | Expression Regulation | PUBMED ID |
|---|---|---|---|---|---|---|---|---|
| CancerPDF_ID268 | FYESDVMGR | Alpha-2-macroglobulin | Plasma | 552.2415 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID269 | HGPEGLRV | Alpha-2-macroglobulin | Plasma | 432.7345 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID1944 | VGFYESDVMGR | Alpha-2-macroglobulin | Serum | 1258.56522 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1945 | FYESDVMGR | Alpha-2-macroglobulin | Serum | 1102.47534 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1946 | SKAIGYLNTGYQR | Alpha-2-macroglobulin | Serum | 1469.76268 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1947 | SLNEEAVKK | Alpha-2-macroglobulin | Serum | 1016.55022 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1948 | SASNMAIVDVK | Alpha-2-macroglobulin | Serum | 1133.57506 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1949 | AIGYLNTGYQR | Alpha-2-macroglobulin | Serum | 1254.63569 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1950 | SKAIGYLNTGYQ | Alpha-2-macroglobulin | Serum | 1313.66157 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1951 | SKAIGYLNTGYQRQLNY | Alpha-2-macroglobulin | Serum | 1988.01157 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1952 | VGFYESDVMGRGHA | Alpha-2-macroglobulin | Serum | 1523.68271 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1953 | VGFYESDVMGR | Alpha-2-macroglobulin | Serum | 1274.56014 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1954 | GFYESDVMGRGHA | Alpha-2-macroglobulin | Serum | 1424.6143 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1955 | AIGYLNTGYQRQLNY | Alpha-2-macroglobulin | Serum | 1772.88458 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1956 | YESDVMGR | Alpha-2-macroglobulin | Serum | 955.40693 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1957 | VGFYESDVMGRGHAR | Alpha-2-macroglobulin | Serum | 1679.78382 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1958 | YESDVMGRG | Alpha-2-macroglobulin | Serum | 1012.42839 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1959 | VGFYESDVMGRG | Alpha-2-macroglobulin | Serum | 1315.58669 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1960 | YESDVMGRGH | Alpha-2-macroglobulin | Serum | 1149.48731 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1961 | IGYLNTGYQRQLNY | Alpha-2-macroglobulin | Serum | 1701.84747 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1962 | VGFYESDVMGRGH | Alpha-2-macroglobulin | Serum | 1452.6456 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1963 | FYESDVMGRGH | Alpha-2-macroglobulin | Serum | 1296.55572 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID4011 | LGSAMQNTQNLLQMPY | Alpha-2-macroglobin | Human milk | NA | MALDI-TOF | Normal | Downregulated 3 fold in Pre-term case as compare to normal | 23891694 |
| CancerPDF_ID4442 | AYLVFSPSKSFV | Alpha-2-macroglobulin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6811 | SFLEDMGLKAF | Alpha-2-macroglobulin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6968 | SLFFTVLQDVPVRDLKPAIV | Alpha-2-macroglobulin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6999 | SLRAFQPFFV | Alpha-2-macroglobulin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7133 | SSTNEKDMYSFLEDMGL | Alpha-2-macroglobulin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7134 | SSTNEKDMYSFLEDMGLK | Alpha-2-macroglobulin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7164 | SVLGDILGSAMQNT | Alpha-2-macroglobulin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID9521 | YESDVMGR | Alpha-2-macroglobulin | Serum | 478.7 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9522 | VGFYESDVMGR | Alpha-2-macroglobulin | Serum | 630.28 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9523 | VGFYESDVMGR | Alpha-2-macroglobulin | Serum | 638.28 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9957 | HALSKYGAAT | Alpha-2-macroglobulin | Urine | 1018.5306 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10159 | YESDVMGRGHARL | Alpha-2-macroglobulin | Urine | 1490.7043 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID11571 | HGPEGLR | Alpha-2-macroglobulin | Serum | 764.39294 | LC-MS | Melanoma | "Present in 6 cancer samples out of 8 cancer samples. ,Present in 1 healthy samples out of 4 healthy samples." | 26992070 |